Product NDC: | 60505-0040 |
Proprietary Name: | Etodolac |
Non Proprietary Name: | Etodolac |
Active Ingredient(s): | 300 mg/1 & nbsp; Etodolac |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-0040 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075419 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030501 |
Package NDC: | 60505-0040-1 |
Package Description: | 100 CAPSULE in 1 BOTTLE (60505-0040-1) |
NDC Code | 60505-0040-1 |
Proprietary Name | Etodolac |
Package Description | 100 CAPSULE in 1 BOTTLE (60505-0040-1) |
Product NDC | 60505-0040 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Etodolac |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20030501 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | ETODOLAC |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |